Description

Semaglutide is a modified form of the naturally occurring peptide GLP-1, which is well-known for its ability to lower blood sugar levels and boost insulin secretion. Studies suggest that Semaglutide may also have beneficial effects on heart, liver, and lung health, and could play a role in slowing or preventing Alzheimer’s disease. Additionally, Semaglutide has been found to significantly reduce appetite by slowing down stomach emptiness and decreasing intestinal movement. As a GLP-1 analog, Semaglutide helps regulate blood sugar by stimulating insulin release and suppressing glucagon secretion in response to glucose levels.

Warning: For Research Purposes Only. Injectables are delivered in a freeze-dried (powder) state, contained within a sterile vial. Use requires: Bacteriostatic Water for reconstitution.